Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arteriovenous Malformations (AVM)

NCT05125471 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT05125471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05125471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arteriovenous Malformations (AVM)
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Completed
Start date
July 26, 2022
Completion date
September 3, 2025
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous malformations (extracranial)